Analyst firms · BTIG · ZBH
BTIG ZBH price target and rating history
Zimmer Biomet Holdings Inc. (ZBH) · Health Care
BTIG rates Zimmer Biomet Holdings Inc. (ZBH) Neutral with a $139 price target, as of its latest action on Mar 23, 2026. It has published 3 rating actions on ZBH since January 2022, including 1 upgrade and 2 downgrades. Across 6 firms with a ZBH price target in the last 12 months, the median target is $100.
- Current rating
- Neutral
- Price target
- $139
- Median target, all firms
- $100
- Actions on ZBH
- 3
Every BTIG rating on ZBH
- Mar 23, 2026DowngradeBTIG downgrades to Neutral from Buy
- Aug 28, 2023
- Jan 10, 2022DowngradeBTIG downgrades to Neutral from Buy
How other firms rate ZBH
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $100 | Oct 7, 2026 |
| UBS | Buy | $115 | Jul 28, 2026 |
| BMO Capital Markets | Market Perform | $95 | Jul 9, 2026 |
| BTIG | Neutral | Mar 23, 2026 | |
| William Blair | Mkt Perform | Feb 20, 2026 | |
| Goldman Sachs | Sell | $93 | Jan 9, 2026 |
| Raymond James | Mkt Perform | Jan 6, 2026 | |
| Evercore ISI | Outperform | $210 | Jan 5, 2026 |
| Robert W. Baird | Neutral | $100 | Dec 16, 2025 |
Questions about BTIG and ZBH
- What is BTIG's price target for ZBH?
- BTIG's latest stated price target for Zimmer Biomet Holdings Inc. (ZBH) is $139, from its action on Aug 28, 2023.
- What is BTIG's rating on ZBH?
- BTIG rates ZBH Neutral, a neutral rating, as of Mar 23, 2026.
- When did BTIG last change its view on ZBH?
- On Mar 23, 2026, BTIG downgrades to Neutral from Buy.
- How does BTIG's ZBH target compare with other analysts?
- Across 6 firms with a ZBH price target in the last 12 months, the median target is $100.
More ZBH rating histories
- Barclays3
- UBS4
- Raymond James3
- Evercore ISI4
- Piper Sandler3
- Jefferies3
- RBC Capital Markets3
- Wells Fargo3
- Needham4
- Truist Securities3
- Loop Capital3
All BTIG ratingsZBH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.